Clinical Trial

Study of BW-50218 in Healthy Participants

Name: Study of BW-50218 in Healthy Participants — clinical trial record (NCT07401472)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2026-02-03; most recent amendment 2026-06-23.

Status change: Not Yet Recruiting → Recruiting 2026-03-03

Trial Details

NCT Number	NCT07401472
Lead Sponsor	Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions	Healthy Participants Study
Enrollment	60 participants
Start Date	2026-03-12
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-24